XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 32,558 [1],[2] $ 27,938
Cash and investments segregated and on deposit for regulatory purposes (including resale agreements of $6,861 at March 31, 2019 and $7,195 at December 31, 2018) 13,924 13,563
Receivables from brokers, dealers, and clearing organizations 616 553
Receivables from brokerage clients — net 20,529 21,651
Other securities owned — at fair value 521 539
Available for sale securities 60,005 66,578
Held to maturity securities 132,420 144,009
Bank loans — net 16,510 16,609
Equipment, office facilities, and property — net 1,813 1,769
Goodwill 1,227 1,227
Other assets 2,692 2,046
Total assets 282,815 296,482
Liabilities and Stockholders’ Equity    
Bank deposits 219,454 231,423
Payables to brokers, dealers, and clearing organizations 1,602 1,831
Payables to brokerage clients 29,701 32,726
Accrued expenses and other liabilities 3,604 2,954
Long-term debt 6,829 6,878
Total liabilities 261,190 275,812
Stockholders’ equity:    
Preferred stock — $.01 par value per share; aggregate liquidation preference of $2,850 2,793 2,793
Common stock — 3 billion shares authorized; $.01 par value per share; 1,487,543,446 shares issued 15 15
Additional paid-in capital 4,548 4,499
Retained earnings 18,017 17,329
Treasury stock, at cost — 153,141,949 shares at March 31, 2019 and 155,116,695 shares at December 31, 2018 (3,677) (3,714)
Accumulated other comprehensive income (loss) (71) (252)
Total stockholders’ equity 21,625 20,670
Total liabilities and stockholders’ equity $ 282,815 $ 296,482
[1] For more information on the nature of restrictions on restricted cash and cash equivalents see Note 15.
[2] Reconciliation of cash, cash equivalents and amounts reported within the balance sheet